Vito Quaranta
Vanderbilt University
H-index: 81
North America-United States
Top articles of Vito Quaranta
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
YAP1 defines a highly plastic, persister cell population in small cell lung cancer (SCLC) following relapse | Cancer Research | C Allison Stewart Sarah M Groves Runsheng Wang Kavya Ramkumar Yuanxin Xi | 2024/3/22 |
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth | Molecular Cancer | J Yang K Bergdorf C Yan W Luo SC Chen | 2023/6/3 |
Analysis of extracellular vesicle surface markers as small cell lung cancer biomarkers | Cancer Research | Patricia M Ozawa Sarah M Groves Vito Quaranta Alissa M Weaver | 2023/4/4 |
Therapeutic methods and compositions for treating cancer using braf and/or mek inhibitor combination therapy | 2023/3/16 | ||
Purinergic calcium signaling drives drug tolerance through ERK reactivation in BRAF-mutant melanoma | bioRxiv | Philip E Stauffer Jordon Brinkley David Jacobson Vito Quaranta Darren R Tyson | 2023/11/5 |
Quantifying cancer cell plasticity with gene regulatory networks and single-cell dynamics | Frontiers in Network Physiology | Sarah Maddox Groves Vito Quaranta | 2023 |
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging data | Engineering with Computers | Guillermo Lorenzo Angela M Jarrett Christian T Meyer Julie C DiCarlo John Virostko | 2023/8/7 |
Unified tumor growth mechanisms from multimodel inference and dataset integration | PLOS Computational Biology | Samantha P Beik Leonard A Harris Michael A Kochen Julien Sage Vito Quaranta | 2023/7/5 |
DDDR-28. EGFR AND SRC-MEDIATED ACTIVATION OF STAT3 DRIVES RESISTANCE TO MITOTIC INHIBITORS IN GLIOBLASTOMA, AND CAN BE REVERSED WITH FDA-APPROVED DRUGS | Neuro-Oncology | Rajappa Kenchappa Athanassios Dovas Michael Argenziano Christian Meyer Lauren Stopfer | 2022/11/1 |
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma | Cell reports | Rajappa S Kenchappa Athanassios Dovas Michael G Argenziano Christian T Meyer Lauren E Stopfer | 2022/6/21 |
Cooperative RNA degradation stabilizes intermediate epithelial-mesenchymal states and supports a phenotypic continuum | Iscience | Benjamin Nordick Mary Chae-Yeon Park Vito Quaranta Tian Hong | 2022/10/21 |
Organoids as a systems platform for SCLC brain metastasis | Frontiers in Oncology | Vito Quaranta Amanda Linkous | 2022/4/28 |
Abstract P1-08-20: In silico analysis of a novel mathematical model integrating in vitro and in vivo imaging data reveals driving mechanisms of breast cancer … | Cancer Research | Guillermo Lorenzo Angela M Jarrett Christian T Meyer Darren R Tyson Vito Quaranta | 2022/2/15 |
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer | Cell systems | Sarah M Groves Geena V Ildefonso Caitlin O McAtee Patricia MM Ozawa Abbie S Ireland | 2022/9/21 |
A heterogeneous drug tolerant persister state in BRAF-mutant melanoma is characterized by ion channel dysregulation and susceptibility to ferroptosis | bioRxiv | Corey E Hayford Philip E Stauffer Blake Baleami B Bishal Paudel Darren R Tyson | 2022/2/5 |
Analysis of transcriptome datasets reveals involvement of epithelial-mesenchymal transition genes in small cell lung cancer phenotypic plasticity | bioRxiv | Sarah M Groves Nicholas Panchy Darren R Tyson Leonard A Harris Vito Quaranta | 2022/9/11 |
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines | Cancer Biology & Therapy | Clayton M Wandishin Charles John Robbins Darren R Tyson Leonard A Harris Vito Quaranta | 2022/12/31 |
Identifying mechanisms driving the early response of triple negative breast cancer patients to neoadjuvant chemotherapy using a mechanistic model integrating in vitro and in … | arXiv preprint arXiv:2212.04270 | Guillermo Lorenzo Angela M Jarrett Christian T Meyer Vito Quaranta Darren R Tyson | 2022/12/8 |
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses | Frontiers in immunology | David Taylor Christian T Meyer Diana Graves Rupashree Sen Juan Fu | 2022/8/19 |
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability | PLoS Biology | Corey E Hayford Darren R Tyson C Jack Robbins III Peter L Frick Vito Quaranta | 2021/6/1 |
Co-Authors
